Enclomiphene before and after: what the evidence shows

Last updated 2026-07-27

What do enclomiphene before and after results actually show?

Most before and after posts you'll find on forums or Reddit follow the same shape: a guy starts around 300 to 400 ng/dL total testosterone, takes 12.5 to 25 mg of enclomiphene daily for 6 to 12 weeks, and comes back with labs in the 600 to 900 ng/dL range. That pattern isn't made up. It lines up with what the published trials found. In a 2013 randomized crossover study of hypogonadal men, enclomiphene citrate raised total testosterone into the eugonadal range while keeping sperm counts and testicular volume essentially unchanged, in contrast to topical testosterone gel which suppressed both ^[1]. A separate Phase 2 dose-ranging trial found that enclomiphene at doses of 12.5 mg to 25 mg daily restored total testosterone to normal levels in a majority of hypogonadal men over a 3-month period, alongside preserved or increased LH and FSH ^[2]. What you won't reliably see in anecdotal before/afters: fertility outcomes. Nobody posting labs on a forum has a semen analysis with sperm concentration and motility pre- and post-treatment, let alone a pregnancy. So when someone says enclomiphene "kept me fertile," what they usually mean is testosterone went up and testicles didn't shrink. That's a real and meaningful distinction from injectable testosterone, but it's not the same claim as "this got my partner pregnant." The honest summary: testosterone and LH/FSH changes in these before/after stories are plausible and trial-supported. Sperm count and pregnancy claims are almost never actually measured by the person posting.

How does enclomiphene compare to TRT for preserving fertility?

This is the actual reason most men research enclomiphene instead of just starting testosterone. Exogenous testosterone (injections, gels, pellets) suppresses the hypothalamic-pituitary-gonadal axis. Your brain senses testosterone in the blood, cuts back GnRH, LH, and FSH drop, and the testicles stop getting the signal to produce sperm and their own testosterone. Testicular volume shrinks over months. Enclomiphene works differently. It's a selective estrogen receptor modulator (SERM), specifically the trans-isomer of clomiphene, and it blocks estrogen receptors at the hypothalamus. The brain reads less estrogen signal, so it releases more GnRH, which drives more LH and FSH, which drives the testicles to make more of their own testosterone (and, because LH and FSH stay elevated instead of crashing, sperm production isn't shut down the way it is on TRT). The 2013 crossover trial comparing enclomiphene to testosterone gel is the clearest single data point here: testosterone gel dropped sperm concentration and testicular volume over the study period, while enclomiphene did not, at comparable increases in serum testosterone ^[1]. That's the mechanistic and clinical basis for calling enclomiphene "fertility-friendly" compared to TRT. It is not proof that enclomiphene improves fertility beyond baseline, and no trial has followed men on enclomiphene through to confirmed pregnancies as a primary endpoint. If preserving the option to have children later is your top priority, this difference matters more than the testosterone number itself. Guys already on TRT who want to reverse suppression sometimes ask about enclomiphene as part of a restart protocol; see Enclomiphene Direct cycle length for how that timing typically works.

Is enclomiphene FDA-approved, and does that change what 'before and after' means?

No. Enclomiphene citrate is not FDA-approved as a standalone drug. It matters here because "before and after" implies a validated product with a known dosing label, and that doesn't exist for enclomiphene the way it does for, say, testosterone cypionate. The drug came closest to approval under the name Androxal, developed by Repros Therapeutics. The company ran multiple Phase 3 trials in the early 2010s. The FDA issued a Complete Response Letter, and Repros never got the drug across the finish line; the program was eventually shelved and the company later merged and moved on from the asset ^{[3] [4]}. As of 2024, there is still no FDA-approved enclomiphene product on the market. What's sold today, including through telehealth routes like Enclomiphene Direct, is compounded enclomiphene, prepared by a compounding pharmacy under a prescription, not a mass-manufactured, FDA-approved drug with an approved label and package insert. That's a legal and important distinction. Compounded drugs are regulated differently: the FDA doesn't review them for safety and efficacy the way it does approved drugs, and they're made under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act depending on the pharmacy type ^[5]. So when you see a before/after post, remember there's no standardized product behind it. Dose, purity, and even isomer content can vary by compounding pharmacy. That's a real source of variability in outcomes that clomiphene-turned-enclomiphene users sometimes don't account for.

Is enclomiphene the same thing as clomiphene (Clomid)?

No, and mixing these up is the single most common error in before/after discussions online. Clomiphene citrate (brand name Clomid) is actually a mixture of two isomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer), roughly in a 62:38 ratio ^[1]. Enclomiphene is the isomer that does most of the anti-estrogenic, LH/FSH-boosting work at the hypothalamus. Zuclomiphene has weaker antiestrogenic activity, a much longer half-life (it can persist in tissue for weeks), and is suspected of contributing to some of the mood and vision side effects associated with clomiphene ^[6]. The theoretical appeal of isolated enclomiphene is getting the useful part without the isomer that lingers and may cause more side effects. In practice, this means: if someone's before/after post is actually describing generic Clomid rather than isolated enclomiphene, their experience includes zuclomiphene exposure too, and their side effect profile (mood changes, visual disturbances) may not transfer to someone using pure enclomiphene. The two are related but they are not interchangeable, and clinical trial data on "clomiphene for hypogonadism" doesn't automatically apply to isolated enclomiphene, or vice versa.

How fast do testosterone levels actually rise on enclomiphene?

In the Phase 2 dose-ranging trial, meaningful increases in total testosterone were seen within the first few weeks of treatment, with most men reaching normal testosterone range by the 3-month mark at doses of 12.5 to 25 mg per day ^[2]. That's consistent with anecdotal before/afters showing 4 to 8 week check-in labs already in normal range. Here's a rough table of what's typically reported, combining trial data ranges and commonly seen anecdotal patterns (labeled as such): | Timepoint | What trials show ^[2] | What anecdotal before/afters typically report |

Does enclomiphene really preserve testicular size?

Yes, this is one of the better-supported claims, though the evidence base is still limited to a small number of trials rather than years of population data. Testicular volume is driven largely by FSH-stimulated spermatogenesis and local testosterone production; both processes shut down under exogenous testosterone. Enclomiphene, by keeping LH and FSH elevated rather than suppressed, avoids that shutdown. The 2013 study by Kim et al. specifically measured testicular volume alongside testosterone and sperm parameters and found preservation on enclomiphene versus decline on testosterone gel over the treatment period ^[1]. This is a real, measured outcome, not an inference. It's also one of the strongest data points supporting the fertility-friendly reputation enclomiphene has in TRT communities. What it doesn't prove: that testicular size preservation translates into normal sperm counts or successful conception in every user. Volume preservation is a proxy, a good one, but a proxy nonetheless.

What side effects show up in enclomiphene before and after reports?

The most commonly reported side effects in trials and in anecdotal reports overlap reasonably well: headache, mood changes, occasional hot flashes, and in some men, an increase in estradiol that needs monitoring ^[2]. Vision changes, a known concern with clomiphene, appear to be rarer with isolated enclomiphene, likely because zuclomiphene (the longer-lingering isomer implicated in visual side effects) isn't present ^[6]. Mood and libido reports in before/afters are mixed. Some men report improved mood and libido tracking with their testosterone rise. Others report irritability or flatness, sometimes tied to estradiol swings rather than testosterone itself. Bloodwork that includes estradiol, more than total testosterone, is the only way to actually sort out which is happening. A before/after post that only shows total T and skips estradiol, LH, and FSH is missing the variables that actually explain how someone feels. Long-term safety data is genuinely thin. The main Androxal trials ran on the order of months, not years ^[3]. If you're considering multi-year use, that's a real gap in the evidence, not a reason to panic, but a reason to get regular labs and not assume the safety profile is fully mapped out.

How should I read testosterone lab numbers in a before/after post?

Total testosterone alone tells you less than people think. A useful before/after should include total testosterone, free testosterone, LH, FSH, and estradiol, ideally drawn at a consistent time of day (morning draws are standard because testosterone follows a diurnal rhythm, highest in the morning) ^[6]. A single afternoon draw showing 900 ng/dL isn't directly comparable to a baseline morning draw of 350 ng/dL; part of that jump could just be timing. Also worth checking: was the baseline actually confirmed with two separate morning draws? Clinical guidance from the Endocrine Society recommends confirming low testosterone with a repeat morning measurement before starting any treatment, because single-sample variability is high . A lot of before/after stories skip this and start from one low number, which inflates the apparent "improvement" once treatment starts. If you're structuring your own tracking, decide your draw time and stick to it every check, and pull the same panel each time (total T, free T, LH, FSH, E2) so before and after numbers are actually comparable.

What does the actual research evidence support and not support?

Supported by trial data: enclomiphene raises total and free testosterone into normal range in men with secondary hypogonadism, over roughly 3 months at 12.5-25 mg/day dosing ^[2]. Supported: it does this while preserving LH, FSH, sperm concentration, and testicular volume, in contrast to testosterone gel, based on a randomized crossover design ^[1]. Supported: it is pharmacologically distinct from and more targeted than clomiphene, isolating the trans-isomer responsible for most of the anti-estrogenic activity ^[1]. Not supported, at least not by controlled trials: pregnancy rate improvements, long-term (multi-year) safety, outcomes in men with primary testicular failure, or outcomes at doses outside the roughly 6.25-25 mg range studied. Also not supported: any claim that a specific compounded formulation performs identically to the specific formulation used in the Repros trials, since compounding pharmacies aren't required to replicate that exact process under FDA review ^[5]. The FDA's own review history is blunt about the gap: Androxal's applications did not satisfy the agency's requirements for approval, and the drug never reached market despite multiple Phase 3 studies ^{[3] [4]}. That's worth sitting with before treating any single before/after post as proof of anything beyond "this compound can raise testosterone in some men."

What should I actually look for before starting enclomiphene?

Baseline labs matter more than any before/after story you'll read. At minimum: two morning total testosterone draws to confirm hypogonadism per Endocrine Society guidance , LH and FSH to distinguish primary from secondary hypogonadism, and estradiol as a baseline for comparison later. If fertility is the actual goal, more than testosterone symptoms, a baseline semen analysis is the only way to know if enclomiphene (or anything else) changed anything. Skipping this step is why so many online claims about enclomiphene and fertility are unverifiable, there's simply no baseline to compare against. Work with a prescriber who will order follow-up labs at 6-8 weeks and adjust dose based on your numbers, not a fixed protocol. For guidance on how doses are typically structured and titrated, see Enclomiphene Direct dosage. If you're being prescribed a reconstituted or injectable form rather than oral capsules, the practical handling questions (reconstitution, injection sites, technique) are covered separately at how to reconstitute Enclomiphene Direct, Enclomiphene Direct how to inject, and Enclomiphene Direct injection sites. Enclomiphene Direct's model is provider-reviewed: a licensed prescriber evaluates your labs and history, and if appropriate, a compounding pharmacy partner fills the prescription. That structure doesn't make the underlying drug FDA-approved, it isn't, but it does mean a clinician is looking at your actual numbers instead of you self-dosing off a forum post.

Frequently asked questions

Are enclomiphene before and after testosterone numbers realistic?

Yes, the general pattern (baseline 300-400 ng/dL rising to 600-900 ng/dL over 4-12 weeks) matches published trial data at 12.5-25 mg/day dosing ^[2]. Individual results vary based on baseline LH/FSH and the cause of low testosterone, so treat any single post as an example, not a guarantee.

Does enclomiphene keep you fertile while raising testosterone?

It preserves LH, FSH, sperm concentration, and testicular volume better than exogenous testosterone in trial data ^[1], which is the basis for its fertility-friendly reputation. No trial has confirmed pregnancy rate outcomes, so "preserves fertility markers" is accurate; "guarantees fertility" is not.

Is enclomiphene FDA-approved?

No. Enclomiphene citrate has never received FDA approval as a standalone drug. The Androxal development program by Repros Therapeutics ran Phase 3 trials but did not gain approval ^[3][4]. What's available today is compounded enclomiphene, prescribed off-label and prepared under compounding pharmacy regulations, not an approved drug label.

What's the difference between enclomiphene and clomiphene?

Clomiphene (Clomid) is a mixture of two isomers, roughly 62% enclomiphene and 38% zuclomiphene ^[6]. Enclomiphene is the isolated trans-isomer, believed to carry most of the testosterone-raising effect with fewer of the side effects linked to zuclomiphene's long tissue half-life ^[7].

How long does it take to see results from enclomiphene?

Trial data shows LH and FSH rising within weeks and total testosterone reaching normal range for most men by around 3 months at 12.5-25 mg/day ^[2]. Some men report symptom changes (energy, libido) earlier, but lab-confirmed normalization typically takes 6-12 weeks.

Does enclomiphene shrink your testicles like TRT does?

No, that's the key mechanistic difference. Testosterone therapy suppresses LH and FSH, shrinking testicles over months. Enclomiphene raises LH and FSH instead, and a randomized crossover trial found testicular volume preserved on enclomiphene while it declined on testosterone gel ^[1].

Can enclomiphene help you get someone pregnant?

It may help by preserving sperm production and testicular function better than TRT, but no controlled trial has measured pregnancy rates as an outcome for enclomiphene. If fertility is your actual goal, get a baseline semen analysis and work with a fertility-informed prescriber rather than relying on testosterone numbers alone.

What side effects show up in enclomiphene users?

Reported side effects include headache, mood changes, hot flashes, and estradiol elevation in some men ^[2]. Vision disturbances associated with clomiphene appear less common with isolated enclomiphene, likely because it lacks zuclomiphene, the isomer more strongly linked to that side effect ^[7].

Is compounded enclomiphene the same as what was tested in clinical trials?

Not necessarily. Compounded products are prepared by pharmacies under Section 503A or 503B of the FD&C Act and are not required to match the exact formulation or process used in the Repros/Androxal Phase 3 trials ^[5]. Potency and purity can vary by pharmacy, which is a real source of outcome variability.

Why did enclomiphene (Androxal) never get FDA approved?

Repros Therapeutics ran multiple Phase 3 trials on Androxal (enclomiphene) for secondary hypogonadism in the early 2010s, but the FDA's review did not result in approval, and the company shelved the program ^[3][4]. It remains available only as a compounded, off-label prescription today.

How should I interpret my own before and after labs on enclomiphene?

Compare total testosterone, free testosterone, LH, FSH, and estradiol, drawn at a consistent time (morning is standard due to diurnal variation) ^[8]. Confirm your baseline with two low readings before starting, per Endocrine Society guidance ^[9], so your "before" number isn't a fluke.

Who is not a good candidate for enclomiphene based on the evidence?

Men with primary testicular failure (high LH/FSH with low testosterone) generally won't respond the way secondary hypogonadism patients did in trials, since enclomiphene works by stimulating a pituitary-testicular axis that's already failing at the testicular level. That distinction requires baseline LH/FSH labs, not guesswork.

Sources

1. Kim ED, et al., Journal of Urology (2013 crossover trial): Enclomiphene raised testosterone while preserving sperm concentration and testicular volume, versus decline with testosterone gel
2. Wiehle R, et al., Phase 2 enclomiphene dose-ranging study, BJU International: Enclomiphene at 12.5-25 mg/day restored testosterone to normal range over about 3 months while preserving LH/FSH
3. FDA, Complete Response Letter history / Androxal NDA review record: Androxal (enclomiphene) did not receive FDA approval despite Phase 3 development
4. Repros Therapeutics SEC filing / corporate history disclosure: Repros Therapeutics' regulatory and corporate filings documenting the Androxal program's history
5. National Center for Biotechnology Information, PubChem entry on clomiphene isomer composition: Clomiphene citrate is a mixture of enclomiphene and zuclomiphene isomers, approximately 62:38 ratio
6. Endocrine Society, Clinical Practice Guideline: Testosterone Therapy in Men with Hypogonadism: Testosterone follows a diurnal rhythm and should be measured via morning blood draws